Literature DB >> 7410546

Cytochemical bioassay of parathyroid hormone: characteristics of the assay and analysis of circulating hormonal forms.

D Goltzman, B Henderson, N Loveridge.   

Abstract

A cytochemical bioassay for parathyroid hormone (PTH) was used for the characterization of the biological activity of circulating forms of the hormone. PTH-stimulated glucose-6-phosphate dehydrogenase activity in distal convoluted tubule cells was quantitated by integrating microdensitometry and the response to native bovine (b)PTH(1-84) was found to be linear between graded doses of hormone from 5 fg/ml to 5 pg/ml. Synthetic bPTH(1-34) and human (h)PTH(1-34) elicited a parallel and equimolar response; however calcitonin, ACTH, glucagon, epinephrine, vasopressin, and insulin failed to significantly stimulate the enzyme in doses up to 100,000 times greater than the lowest concentration of bPTH used. The assay was capable of distinguishing hormonal activity in normal, hypoparathyroid, and hyperparathyroid human plasma. After gel chromatography, bioactivity in plasma of hyperparathyroid patients with skeletal disease but normal kidney function coeluted mainly with bPTH(1-84), whereas bioactivity in plasma of hyperparathyroid patients with skeletal disease but severe uremia coeluted in approximately equivalent amounts with bPTH(1-84) and hPTH(1-34). Despite the abundance of small molecular-weight bioactivity in the peripheral circulation in uremia, approximately 85% of the bioactivity in the parathyroid venous effluent coeluted with bPTH(1-84). The results therefore demonstrate the sensitivity and specificity of the assay for PTH and its utility in measuring the hormone in human parathyroid disorders. The results furthermore demonstrate the importance of entities cochromatographing with bPTH(1-84) in comprising the circulating bioactive hormone in hyperparathyroidism, and support the concept of a biological role for smaller forms of PTH, at least in chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7410546      PMCID: PMC371468          DOI: 10.1172/JCI109794

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Simplified mathematics for bioassays.

Authors:  J H GADDUM
Journal:  J Pharm Pharmacol       Date:  1953-06       Impact factor: 3.765

3.  Metabolism and biological activity of parathyroid hormone in renal cortical membranes.

Authors:  D Goltzman; A Peytremann; E N Callahan; G V Segre; J T Potts
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

Review 4.  The cytochemical bioassay of hormones.

Authors:  J Chayen; J R Daly; N Loveridge; L Bitensky
Journal:  Recent Prog Horm Res       Date:  1976

5.  Clearance of exogenous parathyroid hormone in normal and uraemic man.

Authors:  S E Papapoulos; G N Hendy; S Tomlinson; I G Lewin; J L O'riordan
Journal:  Clin Endocrinol (Oxf)       Date:  1977-09       Impact factor: 3.478

6.  Preliminary studies with the sensitive cytochemical assay for parathyroid hormone.

Authors:  S Fenton; S Somers; D A Heath
Journal:  Clin Endocrinol (Oxf)       Date:  1978-10       Impact factor: 3.478

7.  Examination of the requirement for metabolism of parathyroid hormone in skeletal tissue before biological action.

Authors:  D Goltzman
Journal:  Endocrinology       Date:  1978-05       Impact factor: 4.736

8.  Metabolism of radioiodinated bovine parathyroid hormone in the rat.

Authors:  B V Segre; P D'Amour; J T Potts
Journal:  Endocrinology       Date:  1976-12       Impact factor: 4.736

9.  Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments.

Authors:  J M Canterbury; G S Levey; E Reiss
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

10.  Parathyroid autotransplantation in primary parathyroid hyperplasia.

Authors:  S A Wells; G J Ellis; J C Gunnells; A B Schneider; L M Sherwood
Journal:  N Engl J Med       Date:  1976-07-08       Impact factor: 91.245

View more
  11 in total

1.  Clinical benefits of biochemical markers of bone turnover in Egyptian children with chronic liver diseases.

Authors:  Karam A Mahdy; Hanaa H Ahmed; Fathia Mannaa; Azza Abdel-Shaheed
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

2.  Parathyroid hormone like bioactivity measured by cytochemical bioassay in a patient with malignant bladder disease.

Authors:  S Roche; J F Fielding; N Loveridge
Journal:  Ir J Med Sci       Date:  1988-12       Impact factor: 1.568

3.  [Mid C regional parathyroid hormone in the clinical workup: diagnostic value in extrarenal (primary) and renal (secondary) hyperparathyroidism].

Authors:  H Jüppner; M Atkinson; B Ringe; H P Krohn; R D Hesch
Journal:  Klin Wochenschr       Date:  1986-03-17

Review 4.  "Asymptomatic" and symptomatic primary hyperparathyroidism.

Authors:  J A Fischer
Journal:  Clin Investig       Date:  1993-07

Review 5.  Regulation of parathyroid hormone secretion in vitro and in vivo.

Authors:  J A Fischer; J W Blum; W Born; M A Dambacher; D W Dempster
Journal:  Calcif Tissue Int       Date:  1982-07       Impact factor: 4.333

6.  Neonatal hyperparathyroidism.

Authors:  C A Dezateux; J C Hyde; H M Hoey; J L O'Riordan; L Spitz; G W Taylor; D B Grant
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

7.  Cytochemical bioassay of parathyroid hormone in maternal and cord blood.

Authors:  J Allgrove; S Adami; R M Manning; J L O'Riordan
Journal:  Arch Dis Child       Date:  1985-02       Impact factor: 3.791

8.  Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy.

Authors:  A F Stewart; K L Insogna; D Goltzman; A E Broadus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

9.  Circulating levels of biologically active parathyroid hormone in rheumatic diseases.

Authors:  J Dunham; B E Bourke; L Bitensky; J Chayen; N Loveridge; J T Scott
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

10.  Isolation and analysis of human parathyrin in parathyroid tissue and plasma. Use of reversed-phase liquid chromatography.

Authors:  H P Bennett; S Solomon; D Goltzman
Journal:  Biochem J       Date:  1981-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.